BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38578498)

  • 21. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlating hippocampal and amygdala volumes with neuropathological burden in neurodegenerative diseases using 7T postmortem MRI.
    Liou JJ; Li J; Berardinelli J; Jin H; Santini T; Noh J; Farhat N; Wu M; Aizenstein H; Mettenburg JM; Yong W; Head E; Ikonomovic M; Ibrahim T; Kofler J;
    medRxiv; 2024 May; ():. PubMed ID: 38798514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest Old.
    Montine TJ; Corrada MM; Kawas C; Bukhari SA; White LR; Tian L; Cholerton B
    Neurology; 2022 Sep; 99(10):e1067-e1078. PubMed ID: 35705500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia.
    Huang SH; Hsiao WC; Chang HI; Ma MC; Hsu SW; Lee CC; Chen HJ; Lin CH; Huang CW; Chang CC
    BMC Med Imaging; 2024 Mar; 24(1):75. PubMed ID: 38549082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.
    Sintini I; Schwarz CG; Martin PR; Graff-Radford J; Machulda MM; Senjem ML; Reid RI; Spychalla AJ; Drubach DA; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Hum Brain Mapp; 2019 Apr; 40(5):1618-1631. PubMed ID: 30549156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'MRI-negative PET-positive' temporal lobe epilepsy (TLE) and mesial TLE differ with quantitative MRI and PET: a case control study.
    Carne RP; O'Brien TJ; Kilpatrick CJ; Macgregor LR; Litewka L; Hicks RJ; Cook MJ
    BMC Neurol; 2007 Jun; 7():16. PubMed ID: 17588263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous high-resolution whole-brain MR spectroscopy and [
    Huang H; Zhang M; Zhao Y; Li Y; Jin W; Guo R; Liu W; Cai B; Li J; Yuan S; Huang X; Lin X; Liang ZP; Li B; Luo J
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):721-733. PubMed ID: 37823910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.
    Mosconi L; De Santi S; Li Y; Li J; Zhan J; Tsui WH; Boppana M; Pupi A; de Leon MJ
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):210-21. PubMed ID: 16311757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual [
    Wang J; Guo K; Cui B; Hou Y; Zhao G; Lu J
    Eur Radiol; 2022 Jun; 32(6):3880-3888. PubMed ID: 35024947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis.
    Gauthreaux KM; Teylan MA; Katsumata Y; Mock C; Culhane JE; Chen YC; Chan KCG; Fardo DW; Dugan AJ; Cykowski MD; Jicha GA; Kukull WA; Nelson PT
    Neurology; 2022 Apr; 98(14):e1422-e1433. PubMed ID: 35121671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration.
    Robinson JL; Porta S; Garrett FG; Zhang P; Xie SX; Suh E; Van Deerlin VM; Abner EL; Jicha GA; Barber JM; Lee VM; Lee EB; Trojanowski JQ; Nelson PT
    Brain; 2020 Sep; 143(9):2844-2857. PubMed ID: 32830216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology.
    Torso M; Ridgway GR; Valotti M; Hardingham I; Chance SA; ;
    Alzheimers Res Ther; 2023 Oct; 15(1):165. PubMed ID: 37794477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
    Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
    Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.
    Buciuc M; Wennberg AM; Weigand SD; Murray ME; Senjem ML; Spychalla AJ; Boeve BF; Knopman DS; Jack CR; Kantarci K; Parisi JE; Dickson DW; Petersen RC; Whitwell JL; Josephs KA
    J Alzheimers Dis; 2020; 73(4):1511-1523. PubMed ID: 31929165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related Tauopathy.
    Smirnov DS; Salmon DP; Galasko D; Edland SD; Pizzo DP; Goodwill V; Hiniker A
    Ann Neurol; 2022 Sep; 92(3):425-438. PubMed ID: 35696592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer's disease according to presence of medial temporal lobe atrophy.
    Firbank MJ; Lloyd J; Williams D; Barber R; Colloby SJ; Barnett N; Olsen K; Davison C; Donaldson C; Herholz K; O'Brien JT
    Br J Psychiatry; 2016 May; 208(5):491-6. PubMed ID: 26045347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
    Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL
    Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
    Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
    Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.